Literature DB >> 22550056

Peptides as targeting elements and tissue penetration devices for nanoparticles.

Erkki Ruoslahti1.   

Abstract

The use of nanoparticles in medicine (nanomedicine) has recently become an intensely studied field. Nanoparticles carrying drugs and imaging agents have already reached the clinic, but they are essentially passive delivery vehicles, not what are referred to as "smart" nanoparticles. An important function to add to make nanoparticles smarter is active homing to the target tissue. It makes nanoparticles accumulate in the target tissue at higher concentrations than would be the case without this feature, increasing therapeutic efficacy and reducing side effects. This review discusses the recent developments in the nanoparticle targeting field with emphasis on peptides that home to vascular "zip codes" in target tissues and provide a tissue- and cell-penetrating function.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22550056      PMCID: PMC3947925          DOI: 10.1002/adma.201200454

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   30.849


  88 in total

Review 1.  Tumor angiogenesis: molecular pathways and therapeutic targets.

Authors:  Sara M Weis; David A Cheresh
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

2.  Biomimetic amplification of nanoparticle homing to tumors.

Authors:  Dmitri Simberg; Tasmia Duza; Ji Ho Park; Markus Essler; Jan Pilch; Lianglin Zhang; Austin M Derfus; Meng Yang; Robert M Hoffman; Sangeeta Bhatia; Michael J Sailor; Erkki Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-10       Impact factor: 11.205

3.  Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.

Authors:  Kazuki N Sugahara; Tambet Teesalu; Priya Prakash Karmali; Venkata Ramana Kotamraju; Lilach Agemy; Daniel R Greenwald; Erkki Ruoslahti
Journal:  Science       Date:  2010-04-08       Impact factor: 47.728

4.  Tumor imaging by means of proteolytic activation of cell-penetrating peptides.

Authors:  Tao Jiang; Emilia S Olson; Quyen T Nguyen; Melinda Roy; Patricia A Jennings; Roger Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-15       Impact factor: 11.205

5.  Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours.

Authors:  Vanesa Gregorc; Giovanni Citterio; Giordano Vitali; Anna Spreafico; Paola Scifo; Anna Borri; Giovanni Donadoni; Gilda Rossoni; Angelo Corti; Federico Caligaris-Cappio; Alessandro Del Maschio; Antonio Esposito; Francesco De Cobelli; Flavio Dell'Acqua; Antonella Troysi; Paolo Bruzzi; Antonio Lambiase; Claudio Bordignon
Journal:  Eur J Cancer       Date:  2010-01       Impact factor: 9.162

6.  Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma.

Authors:  Jason A Hoffman; Enrico Giraudo; Mallika Singh; Lianglin Zhang; Masahiro Inoue; Kimmo Porkka; Douglas Hanahan; Erkki Ruoslahti
Journal:  Cancer Cell       Date:  2003-11       Impact factor: 31.743

7.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.

Authors:  Mark E Davis; Jonathan E Zuckerman; Chung Hang J Choi; David Seligson; Anthony Tolcher; Christopher A Alabi; Yun Yen; Jeremy D Heidel; Antoni Ribas
Journal:  Nature       Date:  2010-03-21       Impact factor: 49.962

8.  Genes that distinguish physiological and pathological angiogenesis.

Authors:  Steven Seaman; Janine Stevens; Mi Young Yang; Daniel Logsdon; Cari Graff-Cherry; Brad St Croix
Journal:  Cancer Cell       Date:  2007-06       Impact factor: 31.743

9.  Coupling tumor necrosis factor-alpha with alphaV integrin ligands improves its antineoplastic activity.

Authors:  Flavio Curnis; Anna Gasparri; Angelina Sacchi; Renato Longhi; Angelo Corti
Journal:  Cancer Res       Date:  2004-01-15       Impact factor: 12.701

10.  Nanoparticles that communicate in vivo to amplify tumour targeting.

Authors:  Geoffrey von Maltzahn; Ji-Ho Park; Kevin Y Lin; Neetu Singh; Christian Schwöppe; Rolf Mesters; Wolfgang E Berdel; Erkki Ruoslahti; Michael J Sailor; Sangeeta N Bhatia
Journal:  Nat Mater       Date:  2011-06-19       Impact factor: 43.841

View more
  105 in total

1.  Hypoxia Responsive, Tumor Penetrating Lipid Nanoparticles for Delivery of Chemotherapeutics to Pancreatic Cancer Cell Spheroids.

Authors:  Prajakta Kulkarni; Manas K Haldar; Preeya Katti; Courtney Dawes; Seungyong You; Yongki Choi; Sanku Mallik
Journal:  Bioconjug Chem       Date:  2016-07-27       Impact factor: 4.774

2.  Peptide-targeted liposomal delivery of dexamethasone for arthritis therapy.

Authors:  Rakeshchandra R Meka; Shivaprasad H Venkatesha; Bodhraj Acharya; Kamal D Moudgil
Journal:  Nanomedicine (Lond)       Date:  2019-04-02       Impact factor: 5.307

3.  Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium.

Authors:  Poornima Kolhar; Aaron C Anselmo; Vivek Gupta; Kapil Pant; Balabhaskar Prabhakarpandian; Erkki Ruoslahti; Samir Mitragotri
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-10       Impact factor: 11.205

Review 4.  Nanomedicine therapeutic approaches to overcome cancer drug resistance.

Authors:  Janet L Markman; Arthur Rekechenetskiy; Eggehard Holler; Julia Y Ljubimova
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

Review 5.  Combinatorial peptide libraries: mining for cell-binding peptides.

Authors:  Bethany Powell Gray; Kathlynn C Brown
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

6.  Antibiotic-loaded nanoparticles targeted to the site of infection enhance antibacterial efficacy.

Authors:  Sazid Hussain; Jinmyoung Joo; Jinyoung Kang; Byungji Kim; Gary B Braun; Zhi-Gang She; Dokyoung Kim; Aman P Mann; Tarmo Mölder; Tambet Teesalu; Santina Carnazza; Salvatore Guglielmino; Michael J Sailor; Erkki Ruoslahti
Journal:  Nat Biomed Eng       Date:  2018-01-22       Impact factor: 25.671

Review 7.  Applications of nanoparticles in the detection and treatment of kidney diseases.

Authors:  Chris Brede; Vinod Labhasetwar
Journal:  Adv Chronic Kidney Dis       Date:  2013-11       Impact factor: 3.620

8.  Multifunctional decoration of alpha-tocopheryl succinate-based NP for cancer treatment: effect of TPP and LTVSPWY peptide.

Authors:  Raquel Palao-Suay; María Rosa Aguilar; Francisco J Parra-Ruiz; Sergio Martín-Saldaña; Nathan A Rohner; Susan N Thomas; Julio San Román
Journal:  J Mater Sci Mater Med       Date:  2017-08-31       Impact factor: 3.896

Review 9.  Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms.

Authors:  Yuzhe Sun; Edward Davis
Journal:  Nanomaterials (Basel)       Date:  2021-03-16       Impact factor: 5.076

10.  Application of a proapoptotic peptide to intratumorally spreading cancer therapy.

Authors:  Renwei Chen; Gary B Braun; Xiuquan Luo; Kazuki N Sugahara; Tambet Teesalu; Erkki Ruoslahti
Journal:  Cancer Res       Date:  2012-12-17       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.